Moderna (MEX:MRNA) Land And Improvements : MXN403 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Moderna Land And Improvements?

Moderna's land and improvements for the quarter that ended in Jun. 2024 was MXN403 Mil.

Moderna's quarterly land and improvements increased from Dec. 2023 (MXN373 Mil) to Mar. 2024 (MXN531 Mil) but then declined from Mar. 2024 (MXN531 Mil) to Jun. 2024 (MXN403 Mil).

Moderna's annual land and improvements increased from Dec. 2021 (MXN0 Mil) to Dec. 2022 (MXN214 Mil) and increased from Dec. 2022 (MXN214 Mil) to Dec. 2023 (MXN373 Mil).

Moderna Land And Improvements Historical Data

The historical data trend for Moderna's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Land And Improvements Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

214.46

373.43

Moderna Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Land And Improvements	Get a 7-Day Free Trial															548.61	557.41	373.43	531.08	403.04

Moderna Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil 0QF:Bulgaria MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.